red22
Bluelighter
- Joined
- Nov 23, 2009
- Messages
- 2,063
This is a write-up I made for a Gemini chat (the chat wasn't helpful):
───────────────────────
I'm particularly interested in 5-MeO-DMT's capacity to elevate serotonin because there's evidence that maois render 5-MeO-DMT quite toxic:
"I have heard very mixed reports from trials employing P. harmala and the second of the biotic tryptamines, 5-methoxy-N,N-dimethyl-tryptamine, or 5-MeO-DMT. Apparently, modest amounts of both components gives a modest experience, but I have had two reports of truly toxic crises with larger quantities." Alexander Shulgin. TiHKAL. 1997. Part 1: Chapter 16. Hoasca vs. Ayahuasca, page 302
"I personally had a terrible physical experience from caapi + approx. 5 mg oral of 5-Meo-DMT. I had intense dizzyness/disquilibrium, weakness, alternating extreme hot and cold flashes, overpowering body energy, and intense feelings of malaise. There were no visuals, and I did not feel any kind of ego loss or other psychedelic-like effect." @iom, 2025-04-10, https://www.bluelight.org/community/posts/16249155
"I never had the guts to try this combination again, which I think is probably for the best. When I read Shulgin's TiHKAL in 1999, I read that 5-MeO-DMT in combination with MAOIs has caused some dangerous hypertensive experiences, which certainly fits in with the headaches and pounding heartbeat I experienced." Murple. A Bad Combination. 2000-07-13. https://erowid.org/experiences/exp.php?ID=2362 [This was an experience with 5-MeO-DMT & Peganum harmala]
You might say to this, that's no surprise: MAOIs amplify 5-MeO-DMT's serotonergic action—a well known tight rope in MAOI territory. But Nagai 2007 found that DPT's SRI potency was even stronger than 5-MeO-DMT's SRI potency, and the last person quoted, above, tried DPT with harmine and did not come to the same harsh conclusion:
"Physically, it was a nice trip, after the initial tachycardia passed. I had the usual DPT vibrational feel. I felt very warm and relaxed. The comedown felt very gentle and pleasant." Murple. PropylHuasca. 2000-11-20. https://erowid.org/experiences/exp.php?ID=2383 [This experience also included ketamine, GHB, and cannabis]
Furthermore, he also tried MDMA with P. harmala—more than once—and found it to be a positive combo:
I've mixed MDMA and syrian rue before on several occasions, taking the rue either before or at the same time as the MDMA. I have also mixed Syrian rue with another phenethylamine, mescaline.
Neither caused any problems at all (although when I mixed it with mescaline, I did end up puking, but that happens to me with rue most times anyway, and the mescaline+rue puking was much milder than any tryptamine+rue combination has ever caused). In the case of mixing it with MDMA, it was quite enjoyable and something I will undoubtedly do again. It produces a pretty strong potentiation and adds a new (and quite profound) earthy spiritual dimension to the experience.
The one caution is to use low doses of MDMA. In high enough doses, MDMA itself can kill - as can most amphetamine derivatives. Taking MDMA with an MAOI will lower the overdose threshhold since you are potentiating its effects. If you choose to mix MDMA with Syrian rue, start with no more than half your usual dose of MDMA.
Murple. Combining Ecstasy with Syrian Rue. 2001-07-17. https://erowid.org/experiences/exp.php?ID=8184
Furthermore, I've come across a few people who have used methamphetamine while on an irreversible MAOI without apparent ill effect. One person states that dopamine and norepinephrine amplification is "less of a concern" than serotonin amplification (implying that methamphetamine primarily affects those two chemicals) and "I can personally verify the accuracy of (20mg of vaporized methamphetamine [ … ]) on 30mg nardil not leading to serotonin [toxicity]."[ 1 ] And that's remarkable, as you pointed out that methamphetamine is both an SRI and a serotonin releaser. I also came across someone who had "25 plus instances of combining Nardil with varying amounts of meth, [coke], crack and Ritalin,".[ 2 ] He also said, "I've used [methamphetamine] maybe 20 times, all with no issues, even at much larger doses than the last. The last time I used it in combination with nardil I had a heart attack at 27 and was diagnosed with congenital heart failure"[ 3 ] and "I’ve since smoke lots of crack while still taking the MAOI without any adverse reactions."[ 3 ]
This person puts a big emphasis on these quotes:
"It is, unfortunately, necessary to state clearly from the beginning that much of what is published by doctors in books and journals about MAOIs is either poorly informed, or just plain wrong. As an example, much of the information that comes with MAOIs (the PI, or product information sheet) contains inaccurate material concerning, among other things: serotonin toxicity, drug interactions generally, and dietary tyramine."[ 4 ]
"there is a great deal of misinformation and mythology about their dietary and drug interactions."[ 5 ]
So, how could 5-MeO-DMT be so threatening, in light of this information?
[ 1 ] PowerHungryGandhi, 2024-01-30, https://old.reddit.com/r/harmalas/comments/1aesejh/5meodmt_should_be_combined_with_harmalas_just/kkc5m51/
[ 2 ] No-Tap9133, 2024-04-25, https://old.reddit.com/r/MAOIs/comments/1cc8nz9/three_articles_on_combining_stimulants_with_maois/l17vq64/
[ 3 ] No-Tap9133, 2024-05-22, https://old.reddit.com/r/MAOIs/comments/1cxinm9/curious_to_hear_from_people_who_have_used_meth/l57ynh0/
[ 4 ] Ken Gillman, M.D. MAOIs (Parnate, Nardil): Misconceptions and Questions No. 1. PsychoTropical Research. 2012-11-14. https://web.archive.org/web/2017042...ical.com/maois-misconceptions-and-questions-1
[ 5 ] Grady M.M., Stahl S.M. Practical guide for prescribing MAOIs: debunking myths and removing barriers. 2012. CNS Spectrums. 17(1):2-10. 10.1017/S109285291200003X
https://www.cambridge.org/core/jour...ing-barriers/29CA109F33F4AEC902C3CE39220AD06C
───────────────────────
Some input from Claude, for what it's worth:
───────────────────────
… looking at the Nagai data honestly [see below], it doesn't help much either — 5-MeO-DMT is actually a weaker SRI than several other drugs in those tables that seem better tolerated with MAOIs.
Which leads me to think the answer probably lives somewhere Nagai doesn't measure at all: receptor binding profiles, particularly 5-HT₁A. MDMA's primary action is transporter-mediated release — it floods the synapse with serotonin, but it's the serotonin acting on receptors, not the drug itself directly. 5-MeO-DMT is a direct, potent 5-HT₁A agonist, and unlike most classical psychedelics whose subjective and physiological effects are dominated by 5-HT₂A activity, 5-MeO-DMT's 5-HT₁A affinity is arguably its dominant feature. 5-HT₁A activation is actually associated with the physiological symptoms in your anecdotes — thermoregulatory disruption, cardiovascular effects, the absence of typical psychedelic visuals.
So the honest answer to your question is: the distinction is probably pharmacodynamic rather than pharmacokinetic, and it's likely about where the excess serotonin activity lands rather than simply how much serotonin is elevated. But I want to be clear that this is a hypothesis built from outside literature, not something the Nagai data can support on its own.
───────────────────────
Table 2. The effects of drugs on monoamine re-uptake into rat brain synaptosome [I selected the 5-HT values. These are IC50 values.]
Methamphetamine and cocaine are also included:
Nagai, F., Nonaka, R., & Satoh Hisashi Kamimura, K. 2007. The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. European journal of pharmacology, 559(2-3), 132–137. 10.1016/j.ejphar.2006.11.075
───────────────────────
I'm particularly interested in 5-MeO-DMT's capacity to elevate serotonin because there's evidence that maois render 5-MeO-DMT quite toxic:
"I have heard very mixed reports from trials employing P. harmala and the second of the biotic tryptamines, 5-methoxy-N,N-dimethyl-tryptamine, or 5-MeO-DMT. Apparently, modest amounts of both components gives a modest experience, but I have had two reports of truly toxic crises with larger quantities." Alexander Shulgin. TiHKAL. 1997. Part 1: Chapter 16. Hoasca vs. Ayahuasca, page 302
"I personally had a terrible physical experience from caapi + approx. 5 mg oral of 5-Meo-DMT. I had intense dizzyness/disquilibrium, weakness, alternating extreme hot and cold flashes, overpowering body energy, and intense feelings of malaise. There were no visuals, and I did not feel any kind of ego loss or other psychedelic-like effect." @iom, 2025-04-10, https://www.bluelight.org/community/posts/16249155
"I never had the guts to try this combination again, which I think is probably for the best. When I read Shulgin's TiHKAL in 1999, I read that 5-MeO-DMT in combination with MAOIs has caused some dangerous hypertensive experiences, which certainly fits in with the headaches and pounding heartbeat I experienced." Murple. A Bad Combination. 2000-07-13. https://erowid.org/experiences/exp.php?ID=2362 [This was an experience with 5-MeO-DMT & Peganum harmala]
You might say to this, that's no surprise: MAOIs amplify 5-MeO-DMT's serotonergic action—a well known tight rope in MAOI territory. But Nagai 2007 found that DPT's SRI potency was even stronger than 5-MeO-DMT's SRI potency, and the last person quoted, above, tried DPT with harmine and did not come to the same harsh conclusion:
"Physically, it was a nice trip, after the initial tachycardia passed. I had the usual DPT vibrational feel. I felt very warm and relaxed. The comedown felt very gentle and pleasant." Murple. PropylHuasca. 2000-11-20. https://erowid.org/experiences/exp.php?ID=2383 [This experience also included ketamine, GHB, and cannabis]
Furthermore, he also tried MDMA with P. harmala—more than once—and found it to be a positive combo:
I've mixed MDMA and syrian rue before on several occasions, taking the rue either before or at the same time as the MDMA. I have also mixed Syrian rue with another phenethylamine, mescaline.
Neither caused any problems at all (although when I mixed it with mescaline, I did end up puking, but that happens to me with rue most times anyway, and the mescaline+rue puking was much milder than any tryptamine+rue combination has ever caused). In the case of mixing it with MDMA, it was quite enjoyable and something I will undoubtedly do again. It produces a pretty strong potentiation and adds a new (and quite profound) earthy spiritual dimension to the experience.
The one caution is to use low doses of MDMA. In high enough doses, MDMA itself can kill - as can most amphetamine derivatives. Taking MDMA with an MAOI will lower the overdose threshhold since you are potentiating its effects. If you choose to mix MDMA with Syrian rue, start with no more than half your usual dose of MDMA.
Murple. Combining Ecstasy with Syrian Rue. 2001-07-17. https://erowid.org/experiences/exp.php?ID=8184
Furthermore, I've come across a few people who have used methamphetamine while on an irreversible MAOI without apparent ill effect. One person states that dopamine and norepinephrine amplification is "less of a concern" than serotonin amplification (implying that methamphetamine primarily affects those two chemicals) and "I can personally verify the accuracy of (20mg of vaporized methamphetamine [ … ]) on 30mg nardil not leading to serotonin [toxicity]."[ 1 ] And that's remarkable, as you pointed out that methamphetamine is both an SRI and a serotonin releaser. I also came across someone who had "25 plus instances of combining Nardil with varying amounts of meth, [coke], crack and Ritalin,".[ 2 ] He also said, "I've used [methamphetamine] maybe 20 times, all with no issues, even at much larger doses than the last. The last time I used it in combination with nardil I had a heart attack at 27 and was diagnosed with congenital heart failure"[ 3 ] and "I’ve since smoke lots of crack while still taking the MAOI without any adverse reactions."[ 3 ]
This person puts a big emphasis on these quotes:
"It is, unfortunately, necessary to state clearly from the beginning that much of what is published by doctors in books and journals about MAOIs is either poorly informed, or just plain wrong. As an example, much of the information that comes with MAOIs (the PI, or product information sheet) contains inaccurate material concerning, among other things: serotonin toxicity, drug interactions generally, and dietary tyramine."[ 4 ]
"there is a great deal of misinformation and mythology about their dietary and drug interactions."[ 5 ]
So, how could 5-MeO-DMT be so threatening, in light of this information?
[ 1 ] PowerHungryGandhi, 2024-01-30, https://old.reddit.com/r/harmalas/comments/1aesejh/5meodmt_should_be_combined_with_harmalas_just/kkc5m51/
[ 2 ] No-Tap9133, 2024-04-25, https://old.reddit.com/r/MAOIs/comments/1cc8nz9/three_articles_on_combining_stimulants_with_maois/l17vq64/
[ 3 ] No-Tap9133, 2024-05-22, https://old.reddit.com/r/MAOIs/comments/1cxinm9/curious_to_hear_from_people_who_have_used_meth/l57ynh0/
[ 4 ] Ken Gillman, M.D. MAOIs (Parnate, Nardil): Misconceptions and Questions No. 1. PsychoTropical Research. 2012-11-14. https://web.archive.org/web/2017042...ical.com/maois-misconceptions-and-questions-1
[ 5 ] Grady M.M., Stahl S.M. Practical guide for prescribing MAOIs: debunking myths and removing barriers. 2012. CNS Spectrums. 17(1):2-10. 10.1017/S109285291200003X
https://www.cambridge.org/core/jour...ing-barriers/29CA109F33F4AEC902C3CE39220AD06C
───────────────────────
Some input from Claude, for what it's worth:
───────────────────────
… looking at the Nagai data honestly [see below], it doesn't help much either — 5-MeO-DMT is actually a weaker SRI than several other drugs in those tables that seem better tolerated with MAOIs.
Which leads me to think the answer probably lives somewhere Nagai doesn't measure at all: receptor binding profiles, particularly 5-HT₁A. MDMA's primary action is transporter-mediated release — it floods the synapse with serotonin, but it's the serotonin acting on receptors, not the drug itself directly. 5-MeO-DMT is a direct, potent 5-HT₁A agonist, and unlike most classical psychedelics whose subjective and physiological effects are dominated by 5-HT₂A activity, 5-MeO-DMT's 5-HT₁A affinity is arguably its dominant feature. 5-HT₁A activation is actually associated with the physiological symptoms in your anecdotes — thermoregulatory disruption, cardiovascular effects, the absence of typical psychedelic visuals.
So the honest answer to your question is: the distinction is probably pharmacodynamic rather than pharmacokinetic, and it's likely about where the excess serotonin activity lands rather than simply how much serotonin is elevated. But I want to be clear that this is a hypothesis built from outside literature, not something the Nagai data can support on its own.
───────────────────────
Table 2. The effects of drugs on monoamine re-uptake into rat brain synaptosome [I selected the 5-HT values. These are IC50 values.]
| 2C-I | 7.9±1.9 × 10⁻⁵ |
| 2C-E | 7.2±1.6 × 10⁻⁵ |
| 2C-C | 3.1±0.78 × 10⁻⁵ |
| AMT | 3.8±0.74 × 10⁻⁷ |
| 5-MeO-AMT | 2.9±0.71 × 10⁻⁶ |
| DPT | 2.9±0.69 × 10⁻⁶ |
| 5-MeO-DiPT | 2.2±0.41 × 10⁻⁶ |
| 5-MeO-MiPT | 6.4±1.8 × 10⁻⁶ |
| 5-MeO-DMT | 4.1±0.91 × 10⁻⁶ |
Methamphetamine and cocaine are also included:
| Cocaine | 2.1±0.52 × 10⁻⁶ |
| Methamphetamine | 4.0±0.97 × 10⁻⁶ |
Nagai, F., Nonaka, R., & Satoh Hisashi Kamimura, K. 2007. The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. European journal of pharmacology, 559(2-3), 132–137. 10.1016/j.ejphar.2006.11.075
Last edited:
